Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Arteaus Therapeutics LLC

Headquarters: Cambridge, MA, United States of America
Website: N/A
Year Founded: 2011
Status: Acquired

BioCentury | Oct 16, 2020
Deals

With Disarm deal, Atlas returns to Lilly to take neuro program forward 

Eli Lilly’s acquisition of Disarm marks the second time an Atlas-incubated newco has turned to the pharma to advance its neurology assets.  Under the deal, Eli Lilly and Co. (NYSE:LLY)
BioCentury | Aug 17, 2017
Finance

Built to purpose

How build-to-buy deals are reaching an inflection point
BioCentury | Jan 11, 2016
Strategy

Set them free

Why J&J may spin out core assets without claw-back agreements
BioCentury | Feb 5, 2015
Company News

The Medicines Co. acquires Annovation

BioCentury | Oct 6, 2014
Finance

Atlas' next chapter

What splitting from tech team means for Atlas life science portfolio
BioCentury | May 1, 2014
Strategy

Scripps looks outward

BioCentury | Jan 20, 2014
Company News

Arteaus Therapeutics, Eli Lilly deal

BioCentury | Jan 20, 2014
Finance

Asset-centric milestone

Lilly-Arteaus deal provides Atlas Venture with first asset-centric graduation
Items per page:
1 - 10 of 20